Media Summary: Ritu Salani, MD, MBA, UCLA Health, Los Angeles, CA, discusses the Chair, Jubilee Brown, MD, discusses current and Prof Robert Coleman speaks to ecancer in an online interview for the virtual BGICC 2021 meeting about the

Navigating The Evolving Role Of Immunotherapy In Advanced Endometrial Carcinoma - Detailed Analysis & Overview

Ritu Salani, MD, MBA, UCLA Health, Los Angeles, CA, discusses the Chair, Jubilee Brown, MD, discusses current and Prof Robert Coleman speaks to ecancer in an online interview for the virtual BGICC 2021 meeting about the Domenica Lorusso, MD, PhD, Catholic University of Rome and Fondazione Policlinico Gemelli IRCCS, Rome, Italy, talks on the ... Shannon N. Westin, MD, MPH, FACOG, director of Early Drug Development and Phase I Trials in the Department of Gynecologic ... Tune into Better Edge as we sit down with Emma Barber, MD, director of Robotic Surgery in the Division of Gynecologic Oncology ...

To access the full CME course associated with this video, please visit: ... Benoit You, MD, PhD, Centre Hospitalier Lyon-Sud, Saint-Genis-Laval, France, discusses unmet needs for patients with ...

Photo Gallery

Navigating the evolving role of immunotherapy in advanced endometrial carcinoma
Role of immunotherapy in advanced endometrial cancer: recent developments and future directions
The evolving standard of care for advanced/recurrent endometrial cancer
What is the Role of Immunotherapy in Endometrial Cancer?
Maximizing the of Potential Current and Emerging Immunotherapies in Advanced Endometrial Cancer
Incorporating immunotherapy in cervical cancer and endometrial cancer treatment: 2022 ESMO Florida
Evolving medical treatment in advanced/recurrent endometrial cancer
Immunotherapy in Advanced Endometrial Cancer – The New Standard of Care
Immunotherapy as a Treatment Cornerstone for Advanced Endometrial Cancer
Advances in Endometrial Carcinoma Treatment: The Power of Immunotherapy and Other Emerging Regimens
Latest developments in immunotherapy for advanced/recurrent endometrial cancer
Immunotherapy Advances the Treatment Landscape of Endometrial Cancers
Sponsored
Sponsored
View Detailed Profile
Navigating the evolving role of immunotherapy in advanced endometrial carcinoma

Navigating the evolving role of immunotherapy in advanced endometrial carcinoma

Updates on

Role of immunotherapy in advanced endometrial cancer: recent developments and future directions

Role of immunotherapy in advanced endometrial cancer: recent developments and future directions

Ritu Salani, MD, MBA, UCLA Health, Los Angeles, CA, discusses the

Sponsored
The evolving standard of care for advanced/recurrent endometrial cancer

The evolving standard of care for advanced/recurrent endometrial cancer

Advancing

What is the Role of Immunotherapy in Endometrial Cancer?

What is the Role of Immunotherapy in Endometrial Cancer?

What is

Maximizing the of Potential Current and Emerging Immunotherapies in Advanced Endometrial Cancer

Maximizing the of Potential Current and Emerging Immunotherapies in Advanced Endometrial Cancer

Chair, Jubilee Brown, MD, discusses current and

Sponsored
Incorporating immunotherapy in cervical cancer and endometrial cancer treatment: 2022 ESMO Florida

Incorporating immunotherapy in cervical cancer and endometrial cancer treatment: 2022 ESMO Florida

Dr Brian Slomovitz discusses an

Evolving medical treatment in advanced/recurrent endometrial cancer

Evolving medical treatment in advanced/recurrent endometrial cancer

Prof Robert Coleman speaks to ecancer in an online interview for the virtual BGICC 2021 meeting about the

Immunotherapy in Advanced Endometrial Cancer – The New Standard of Care

Immunotherapy in Advanced Endometrial Cancer – The New Standard of Care

Immunotherapy

Immunotherapy as a Treatment Cornerstone for Advanced Endometrial Cancer

Immunotherapy as a Treatment Cornerstone for Advanced Endometrial Cancer

Immunotherapy

Advances in Endometrial Carcinoma Treatment: The Power of Immunotherapy and Other Emerging Regimens

Advances in Endometrial Carcinoma Treatment: The Power of Immunotherapy and Other Emerging Regimens

This content has been

Latest developments in immunotherapy for advanced/recurrent endometrial cancer

Latest developments in immunotherapy for advanced/recurrent endometrial cancer

Domenica Lorusso, MD, PhD, Catholic University of Rome and Fondazione Policlinico Gemelli IRCCS, Rome, Italy, talks on the ...

Immunotherapy Advances the Treatment Landscape of Endometrial Cancers

Immunotherapy Advances the Treatment Landscape of Endometrial Cancers

Shannon N. Westin, MD, MPH, FACOG, director of Early Drug Development and Phase I Trials in the Department of Gynecologic ...

Understanding Immunotherapy for Endometrial Cancer | iCliniq

Understanding Immunotherapy for Endometrial Cancer | iCliniq

Endometrial cancer

Evolving medical treatment in advanced / recurrent endometrial cancer

Evolving medical treatment in advanced / recurrent endometrial cancer

Evolving

Transforming Second-Line Immunotherapy for Endometrial Cancer

Transforming Second-Line Immunotherapy for Endometrial Cancer

Tune into Better Edge as we sit down with Emma Barber, MD, director of Robotic Surgery in the Division of Gynecologic Oncology ...

Treatment of Advanced Endometrial Cancer

Treatment of Advanced Endometrial Cancer

To access the full CME course associated with this video, please visit: ...

Refining the Role of Immune Checkpoint Inhibitors in Endometrial Cancer

Refining the Role of Immune Checkpoint Inhibitors in Endometrial Cancer

Chair, Bhavana Pothuri, MD, MS discusses

KEYTRUDA: CURE FOR ADVANCED ENDOMETRIAL CANCER?

KEYTRUDA: CURE FOR ADVANCED ENDOMETRIAL CANCER?

Endometrial cancer

The role of immunotherapy  in womb cancer

The role of immunotherapy in womb cancer

Peaches Womb

Research priorities for metastatic endometrial cancer

Research priorities for metastatic endometrial cancer

Benoit You, MD, PhD, Centre Hospitalier Lyon-Sud, Saint-Genis-Laval, France, discusses unmet needs for patients with ...